Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity Akira SasakiKoutaro YokoteJoint Committee in the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, the Japan Society for the Study of Obesity Report of the Committee 08 November 2021 Pages: 1 - 30
Correction to: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity Akira SasakiKoutaro YokoteJoint Committee in the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, the Japan Society for the Study of Obesity Correction 26 November 2021 Pages: 31 - 32
Correction to: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity Akira SasakiKoutaro YokoteJoint Committee in the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, the Japan Society for the Study of Obesity Correction 07 December 2021 Pages: 33 - 34
Metformin action in the gut―insight provided by [18F]FDG PET imaging Hitomi TsuchidaYasuko MoritaWataru Ogawa Commentary 23 September 2021 Pages: 35 - 40
Understanding the quality of diabetes care in Japan: a systematic review of the literature Joanna MitriTakehiro SugiyamaRobert A. Gabbay Review Article 01 March 2021 Pages: 41 - 48
The forgotten type 2 diabetes mellitus medicine: rosiglitazone Bo XuAoxiang XingShuwei Li Review Article 29 June 2021 Pages: 49 - 65
Study on the effects of changes in lifestyle of patients with diabetes on glycaemic control before and after the declaration of the state of emergency in Japan Mio MasudaOsamu Tomonaga Original Article 20 April 2021 Pages: 66 - 74
A randomized controlled trial of a structured program combining aerobic and resistance exercise for adults with type 2 diabetes in Japan Yasuo TerauchiTetsushi TakadaSatoshi Yoshida Original Article 28 April 2021 Pages: 75 - 84
The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study Yukako HosomiChihiro MunekawaMichiaki Fukui Original Article 19 April 2021 Pages: 85 - 90
Efficacy of dulaglutide after switching from incretin-related drugs in patients with type 2 diabetes and inadequate glycemic control Hiroyuki ItoRie ArakiMichiko Togane Original Article 29 April 2021 Pages: 91 - 100
Prevalence and predictors of atrial fibrillation in Japanese patients with type 2 diabetes Sachiko OtakeAsako SatoTetsuya Babazono Original Article 16 May 2021 Pages: 101 - 107
Evaluation of perceived fears of COVID-19 virus infection and its relationship to health-related quality of life among patients with diabetes mellitus in Egypt during pandemic: a developing country single-center study Mohamed AbdelghaniMohamed G. HamedEman Fouad Original Article 12 May 2021 Pages: 108 - 116
Two-year administration of sodium-glucose co-transporter 2 inhibitor brought about marked reduction of body fat independent of skeletal muscle amount or glycemic improvement in Japanese patients with type 2 diabetes Moeko SakamotoYuka GotoMasatoshi Nomura Original Article 21 May 2021 Pages: 117 - 123
Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial Fukumi YoshikawaHiroshi UchinoTakahisa Hirose Original Article 05 June 2021 Pages: 124 - 131
Patient characteristics associated with improvement in glycemic control following addition of an oral antidiabetic drug to DPP-4 inhibitor monotherapy in Japanese patients with type 2 diabetes mellitus (JDDM 60) Koichi KawaiJun-ichi EikiJapan Diabetes Clinical Data Management Study Group (JDDM) Original Article 15 July 2021 Pages: 132 - 141
Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross-sectional study according to age and clinical background Fukumi YoshikawaNaoki KumashiroTakahisa Hirose Original Article 02 June 2021 Pages: 142 - 147
Decline in the estimated glomerular filtration rate (eGFR) following metabolic control and its relationship with baseline eGFR in type 2 diabetes with microalbuminuria or macroalbuminuria Shoichi AkazawaEiji SadashimaNobuhiko Koga Original Article 29 July 2021 Pages: 148 - 159
Variables associated with adherence to the treatment of type 2 diabetes mellitus among elderly people Rinaldo Eduardo Machado de OliveiraJulieta Mieko UetaLaercio Joel Franco Original Article 17 June 2021 Pages: 160 - 168
Cross sectional study on proportion of sulfonylureas among various oral antidiabetic drugs using for Japanese patients with type 2 diabetes, analyzed from NSAID Study-2 Keiko AraiTetsuo NishikawaHisao Mori Original Article 11 July 2021 Pages: 169 - 176
A cross-sectional study of the correlation between diabetic therapy and serum zinc concentrations Mamoru SakuraiJunko SasakiRyo Suzuki Original Article 10 July 2021 Pages: 177 - 187
Cut-off values and clinical efficacy of body roundness index and other novel anthropometric indices in identifying metabolic syndrome and its components among Southern-Indian adults Chiranjeevi Kumar EndukuruGirwar Singh GaurBalasubramaniyan Vairappan Original Article 18 July 2021 Pages: 188 - 200
Association of a SNP in the IAPP gene and hyperglycemia on β-cell dysfunction in type 2 diabetes: the Toon Genome Study Ryoichi KawamuraYasuharu TabaraHaruhiko Osawa Original Article 12 August 2021 Pages: 201 - 208
Electrolyzed hydrogen-rich water for oxidative stress suppression and improvement of insulin resistance: a multicenter prospective double-blind randomized control trial Susumu OgawaYusuke OhsakiSadayoshi Ito Original Article 18 July 2021 Pages: 209 - 219
Association of family history of type 2 diabetes with blood pressure and resting heart rate in young normal weight Japanese women Mari HondaAyaka TsuboiKeisuke Fukuo Original Article 23 July 2021 Pages: 220 - 225
Glycated albumin (GA) and the GA/HbA1c ratio are higher in diabetic patients positive for insulin antibodies with high binding capacity and low affinity Takehito TakeuchiYushi HirotaMasafumi Koga Original Article 18 August 2021 Pages: 226 - 231
Explaining the obesity paradox in healthcare utilization among people with type 2 diabetes Virender KumarWilliam Encinosa Original Article 07 September 2021 Pages: 232 - 243
Glycemic control and number of natural teeth: analysis of cross-sectional Japanese employment-based dental insurance claims and medical check-up data Kayo HaradaKatsutaro MorinoHiroshi Maegawa Original Article 28 August 2021 Pages: 244 - 252
Work-related factors related to forgetting to take oral diabetes medication during the working day among Japanese male employees with diabetes Nao SonodaSoichiro WatanabeAkiko Morimoto Original Article 21 August 2021 Pages: 253 - 261
Tailored notification encouraging examinees with abnormal glucose levels in health checkups to seek medical care Miki NagafuchiHirokazu TakahashiKimie Fujita Original Article 26 August 2021 Pages: 262 - 271
Vomiting and hyperkalemia are novel clues for emergency room diagnosis of type 1 diabetic ketoacidosis: a retrospective comparison between diabetes types Tomoko TakaiYuko OkadaTakehiro Nakamura Original Article 05 September 2021 Pages: 272 - 279
A sensor augmented pump may improve awareness of hypoglycemia and quality of life in Japanese patients with type 1 diabetes mellitus Satoshi TakagiJunnosuke MiuraTetsuya Babazono Original Article 02 September 2021 Pages: 280 - 287
Japanese Type 1 Diabetes Database Study (TIDE-J): rationale and study design Daisuke ChujoAkihisa ImagawaHiroshi Kajio Original Article 06 September 2021 Pages: 288 - 294
Hypoglycemic coma in an elderly adult switched from twice-daily vildagliptin to once-daily glimepiride to improve drug adherence Shunsuke TominariMegumi YasudaDaisuke Yabe Case Report 05 May 2021 Pages: 295 - 299
Dupilumab-related type 1 diabetes in a patient with atopic dermatitis: a case report Yasuharu KurokawaYoichi OikawaKen Yajima Case Report 10 August 2021 Pages: 300 - 303
Changes in glucagon secretion induced by food intake in fulminant type 1 diabetes mellitus: a case report Natsumi HimenoTsuguka MatsudaMasayasu Yoneda Case Report 06 August 2021 Pages: 304 - 308
Non-autoimmune acute-onset type 1 diabetes mellitus newly developed in an elderly patient presenting elevation of serum pancreatic exocrine enzymes Akinori KanzakiMorihiro MatsudaTadashi Nakamura Case Report 26 August 2021 Pages: 309 - 313
Correction to: Non-autoimmune acute-onset type 1 diabetes mellitus newly developed in an elderly patient presenting elevation of serum pancreatic exocrine enzymes Akinori KanzakiMorihiro MatsudaTadashi Nakamura Correction 30 September 2021 Pages: 314 - 314
Acute esophageal necrosis complicating diabetic ketoacidosis in a patient with type II diabetes mellitus and excessive cola consumption: a case report Despoina AvramidouParaskevi ViolatziVasileios Papadopoulos Case Report 27 August 2021 Pages: 315 - 319
Formation of large abscess tumor including gallstone in ileum during therapy for hyperosmolar hyperglycemic syndrome: a case report Takatoshi AnnoFumika MinakawaHideaki Kaneto Case Report 31 August 2021 Pages: 320 - 324
Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials Fotios BarkasGeorgia AnastasiouEvangelos Liberopoulos Short Communication 06 June 2021 Pages: 325 - 329
A case of α-chain variant hemoglobin (Hb Chad) with falsely high HbA1c levels measured by immunoassay Kei YoshinoYushi HirotaMasafumi Koga Short Communication 13 August 2021 Pages: 330 - 335
Correction to: Glycemic control of people with diabetes over months after the 2018 North Osaka Earthquake Hirotaka WatanabeMitsuyoshi TakaharaIichiro Shimomura Correction 23 October 2021 Pages: 336 - 336